Decidual Cell Adaptations to Physiological Stressors

蜕膜细胞对生理应激源的适应

基本信息

  • 批准号:
    7246417
  • 负责人:
  • 金额:
    $ 30.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-12 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The establishment and maintenance of pregnancy require appropriate development of a specialized maternal tissue, referred to as decidua. Decidual cells arise from uterine stroma via the actions of progesterone, form intimate relationships with placental structures, and facilitate the development of the embryo. The actions of progesterone are mediated, in part, through activation of the transcriptional regulator CCAAT/enhancer binding protein (3 (C/EBP¿). Among the important functions of decidual cells are their hormone/cytokine producing capabilities. Hormone/cytokines related to prolactin (PRL) are prominent decidual cell secretory proteins and include decidual prolactin-related protein (dPRP). The uteroplacental PRL family has been implicated in the regulation of uterine inflammatory cell responses accompanying pregnancy. We propose that dPRP modulates intrauterine responses to inflammation/physiological stressors, including inhibiting decidual cell stress and preserving vascular integrity. Dysregulation of dPRP results in decidual cell stress (including upregulation of CHOP) and vascular instability. CHOP is a known inhibitor of C/EBP¿ actions, and its activation potentially compromises decidual cell function. Disruptions in decidual cell function and in vascular integrity increase susceptibility to pregnancy failure. In this research project, we plan to investigate the regulation of decidual cell adaptations to physiological stressors. In Specific Aim No. 1 we investigate factors impacting and mediating decidual adaptations to physiological stressors. Specific Aim No. 2 assesses the role of dPRP and human PRL in the regulation of adaptations to physiological stressors. The third Aim investigates the role of CHOP in the dysregulation of decidual cell function following exposure to physiological stressors. Each Aim is entirely independent and will be started at the beginning of year one of the grant period and will proceed in parallel through the end of the proposed grant period. The planned research utilizes cellular and molecular and in vitro and in vivo strategies. Data derived from the proposed experimentation will improve our understanding of the nature of decidual cell signaling and the role of the decidual PRL family in the regulation of viviparity. These findings will provide considerable insight into the etiology of developmental disorders associated with pregnancy failure and will also have important ramifications on our understanding of adaptations to physiological stressors.
描述(由申请人提供):妊娠的建立和维持需要适当发育专门的母体组织,称为蜕膜。蜕膜细胞通过孕酮的作用从子宫基质中产生,与胎盘结构形成密切关系,并促进胚胎的发育。孕酮的作用部分通过激活转录调节因子CCAAT/增强子结合蛋白(3(C/EBP))介导。蜕膜细胞的重要功能之一是它们产生激素/细胞因子的能力。催乳素(PRL)相关的激素/细胞因子是重要的蜕膜细胞分泌蛋白,包括蜕膜催乳素相关蛋白(dPRP)。子宫胎盘催乳素家族与妊娠相关的子宫炎性细胞反应的调节有关。我们提出dPRP调节子宫内对炎症/生理应激的反应,包括抑制蜕膜细胞应激和保持血管完整性。dPRP的失调导致蜕膜细胞应激(包括CHOP的上调)和血管不稳定。CHOP是一种已知的C/EBP作用抑制剂,其激活可能会损害蜕膜细胞功能。蜕膜细胞功能和血管完整性的破坏增加了妊娠失败的易感性。在本研究计划中,我们计划研究蜕膜细胞对生理应激的适应性调节。在具体目标1中,我们研究影响和介导蜕膜适应生理应激的因素。具体目标2评估了dPRP和人PRL在生理应激适应调节中的作用。第三个目的是研究CHOP在暴露于生理应激后蜕膜细胞功能失调中的作用。每个目标都是完全独立的,将在赠款期的第一年开始,并将在建议的赠款期结束时平行进行。计划中的研究利用细胞和分子以及体外和体内策略。来自拟议的实验数据将提高我们的了解蜕膜细胞信号的性质和蜕膜PRL家族在胎生调控中的作用。这些发现将提供相当深入的了解与妊娠失败相关的发育障碍的病因,也将有重要的影响,我们对适应生理应激源的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL J SOARES其他文献

MICHAEL J SOARES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL J SOARES', 18)}}的其他基金

Trophoblast-Guided Uterine Transformation in the Establishment of Pregnancy
滋养细胞引导子宫转化以建立妊娠
  • 批准号:
    10446395
  • 财政年份:
    2022
  • 资助金额:
    $ 30.5万
  • 项目类别:
Trophoblast-Guided Uterine Transformation in the Establishment of Pregnancy
滋养细胞引导子宫转化以建立妊娠
  • 批准号:
    10622609
  • 财政年份:
    2022
  • 资助金额:
    $ 30.5万
  • 项目类别:
Trophoblast-Uterine Cell Dynamics at the Maternal-Fetal Interface
母胎界面的滋养层-子宫细胞动力学
  • 批准号:
    10271279
  • 财政年份:
    2020
  • 资助金额:
    $ 30.5万
  • 项目类别:
Anti-Coagulation Factors and Placentation
抗凝因子和胎盘植入
  • 批准号:
    10632127
  • 财政年份:
    2019
  • 资助金额:
    $ 30.5万
  • 项目类别:
Anti-Coagulation Factors and Placentation
抗凝因子和胎盘植入
  • 批准号:
    10164839
  • 财政年份:
    2019
  • 资助金额:
    $ 30.5万
  • 项目类别:
Anti-Coagulation Factors and Placentation
抗凝因子和胎盘植入
  • 批准号:
    9978901
  • 财政年份:
    2019
  • 资助金额:
    $ 30.5万
  • 项目类别:
Anti-Coagulation Factors and Placentation
抗凝因子和胎盘植入
  • 批准号:
    10403684
  • 财政年份:
    2019
  • 资助金额:
    $ 30.5万
  • 项目类别:
RESEARCH PROJECT III: Histone H3K9 Methylation and Trophoblast Lineage Developmen
研究项目 III:组蛋白 H3K9 甲基化和滋养层谱系发育
  • 批准号:
    9341564
  • 财政年份:
    2016
  • 资助金额:
    $ 30.5万
  • 项目类别:
Natural Killer Cells and Hemochorial Placentation
自然杀伤细胞和血绒质胎盘着床
  • 批准号:
    8810079
  • 财政年份:
    2015
  • 资助金额:
    $ 30.5万
  • 项目类别:
Natural Killer Cells and Hemochorial Placentation
自然杀伤细胞和血绒质胎盘着床
  • 批准号:
    9036420
  • 财政年份:
    2015
  • 资助金额:
    $ 30.5万
  • 项目类别:

相似海外基金

Control of ovarian vascular remodeling by CCAAT/enhancer binding proteins alpha and beta
CCAAT/增强子结合蛋白α和β控制卵巢血管重塑
  • 批准号:
    10503652
  • 财政年份:
    2022
  • 资助金额:
    $ 30.5万
  • 项目类别:
Control of ovarian vascular remodeling by CCAAT/enhancer binding proteins alpha and beta
CCAAT/增强子结合蛋白α和β控制卵巢血管重塑
  • 批准号:
    10684822
  • 财政年份:
    2022
  • 资助金额:
    $ 30.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了